What question did this study set out to answer?

To review contemporary advancements, current drug candidates, and associated risks of conventional chemotherapy alongside emerging targeted therapeutic strategies in cancer management.

March 18, 2022Genes & DiseasesOpen Access

Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics

View Full Paper

Ask AI

Bookmark

Authors

UAUttpal AnandSam Higginbottom Institute of Agriculture ADAbhijit DeyTechno India University ACArvind K. Singh ChandelUniversity of Bern

Discussion

Member takes

Implication

Review reveals the evolving landscape of chemotherapy and targeted therapies in cancer patients, highlighting shifting paradigms toward precision oncology.

Key Points

To review contemporary advancements, current drug candidates, and associated risks of conventional chemotherapy alongside emerging targeted therapeutic strategies in cancer management.
Literature-based narrative review evaluating existing chemotherapeutic agents and contemporary clinical drug candidates.
Synthesized evidence across targeted drug therapies, immunotherapy, personalized medicine, and cancer type-specific biomarkers.
Conventional chemotherapy persists as the primary frontline strategy for advanced malignancies unsuitable for surgery or radiation, despite significant physical and psychological toxicities.
Novel interventions incorporating cancer type-specific biomarkers, immunotherapy, and targeted regimens demonstrate qualitative improvements in clinical outcomes and disease-free survival.

Cite This Study

Anand et al. (2022) studied this question.

synapsesocial.com/papers/69d73d338e958094d1b8a68d https://doi.org/10.1016/j.gendis.2022.02.007

View Full Paper

Ask AI

Bookmark

Implication

Review reveals the evolving landscape of chemotherapy and targeted therapies in cancer patients, highlighting shifting paradigms toward precision oncology.

Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics

Discussion

Member takes

Implication

Key Points

Cite This Study

Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider